Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-22-002651

Options or other derivatives

  • Chief Scientific Officer acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MacBeath Gavin · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-18 Grant or award : show line 1 in the form Stock Option (Right to Buy) +140,000 140,000 D
Loading xslF345X03/doc4.xml…